Sunder Mudaliar

15.5k citations

118 papers · 9.4k indexed · 4 hit papers · h-index 51

Impact in

Endocrinology, Diabetes and Metabolism top 0.1%
- Diabetes Treatment and Management
- Diabetes Management and Research
Endocrine and Autonomic Systems top 0.5%

Papers in

Endocrinology, Diabetes and Metabolism 59
- Diabetes Treatment and Management 37
- Diabetes Management and Research 18
- Diabetes, Cardiovascular Risks, and Lipoproteins 13
Physiology 39
- Adipose Tissue and Metabolism 24
- Diet and metabolism studies 11

Co-authors: Robert R. Henry Theodore P. Ciaraldi Svetlana E. Nikoulina Dennis Dong Hwan Kim Leslie Carter J. Erickson Raymond A Plodkowski Eduardo Dunayevich
Journals: The Journal of Clinical Endocrinology & Metabolism (14 papers)Diabetes (12 papers)Diabetes Care (12 papers)Diabetes Obesity and Metabolism (12 papers)Metabolism (6 papers)
Partner nations: United States Italy India

In The Last Decade

Sunder Mudaliar

118 papers receiving 9.0k citations

Hit Papers

align trajectories log scale

Efficacy and Safety of the Farnesoid X Receptor Agonist Obeticholic Acid in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease 2013 · 767 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2013 Gastroenterology
2011 New England Journal of Medicine
2010 The Lancet
1996 Diabetes

Peers

Countries citing papers authored by Sunder Mudaliar

Since Specialization

Citations

This map shows the geographic impact of Sunder Mudaliar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sunder Mudaliar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sunder Mudaliar more than expected).

Fields of papers citing papers by Sunder Mudaliar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sunder Mudaliar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sunder Mudaliar. The network helps show where Sunder Mudaliar may publish in the future.

Co-authors

The 25 scholars most cited alongside Sunder Mudaliar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sunder Mudaliar Line = papers co-authored together Sunder Mudaliar links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Astaxanthin, a natural antioxidant, lowers cholesterol and markers of cardiovascular risk in individuals with prediabetes and dyslipidaemia Diabetes Obesity and Metabolism ·Theodore P. Ciaraldi, Schafer Boeder, Sunder Mudaliar, Erin R. Giovannetti, Robert R. Henry, Jeremy Pettus	2023	22
2	Effect of canagliflozin treatment on hepatic triglyceride content and glucose metabolism in patients with type 2 diabetes Diabetes Obesity and Metabolism ·Kenneth Cusi, Fernando Bril, Diana Barb, David Polidori, Sue Sha, Atalanta Ghosh, 公義塚崎, Nishanth E. Sunny, Srilaxmi Kalavalapalli, Jeremy Pettus, Theodore P. Ciaraldi, Sunder Mudaliar, Robert R. Henry	2018	137
3	Predictive factors associated with three years of response to HbA1c goals with exenatide QW or insulin glargine: Post‐hoc analysis of the DURATION‐3 study Diabetes Obesity and Metabolism ·Bruno Guerci, Michael Trautmann, Tim Lin, Elise Hardy, Sunder Mudaliar	2018	1
4	Efficacy of Autologous Bone Marrow-Derived Mesenchymal Stem Cell and Mononuclear Cell Transplantation in Type 2 Diabetes Mellitus: A Randomized, Placebo-Controlled Comparative Study Stem Cells and Development ·Shobhit Bhansali, Pinaki Dutta, Vinod Kumar, Mukesh Yadav, Ashish Jain, Sunder Mudaliar, Shipra Bhansali, Ratti Ram Sharma, Vivekanand Jha, Neelam Marwaha, Niranjan Khandelwal, Anand Srinivasan, Naresh Sachdeva, Meredith Hawkins, Anil Bhansali	2016	86
5	Diabetes Incidence and Glucose Tolerance after Termination of Pioglitazone Therapy: Results from ACT NOW The Journal of Clinical Endocrinology & Metabolism ·Devjit Tripathy, Dawn C. Schwenke, Società italiana per l'organizzazione internazionale, George A. Bray, Thomas A. Buchanan, Stephen Clement, Robert R. Henry, Abbas E. Kitabchi, Sunder Mudaliar, Robert E. Ratner, Frankie B. Stentz, Nicolas Musi, Peter D. Reaven, Ralph A. DeFronzo	2016	35
6	Altered Myokine Secretion Is an Intrinsic Property of Skeletal Muscle in Type 2 Diabetes PLoS ONE ·Theodore P. Ciaraldi, Gregory Roscoe, Sunder Mudaliar, Robert R. Henry	2016	60
7	Changes in Insulin Sensitivity and Insulin Secretion with the Sodium Glucose Cotransporter 2 Inhibitor Dapagliflozin Diabetes Technology & Therapeutics ·Sunder Mudaliar, Robert R. Henry, Guenther Boden, Steven R. Smith, Alexandros-Georgios Chalamandaris, Mikael Alvesved, Nayyar Iqbal, James F. List	2013	89
8	Efficacy and Safety of the Farnesoid X Receptor Agonist Obeticholic Acid in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease Gastroenterology ·Sunder Mudaliar, Robert R. Henry, Arun J. Sanyal, Linda Morrow, Hanns–Ulrich Marschall, Mark Kipnes, Luciano Adorini, Maxine V. Shiner, Paul Clopton, Erin Castelloe, Paul Dillon, Mark Pruzanski, Д. А. Шапиро Hit paper breakdown →	2013	767
9	Evolution of Exenatide as a Diabetes Therapeutic Current Diabetes Reviews ·Sunil Bhavsar, Sunder Mudaliar, Alan D. Cherrington	2013	63
10	Impact of olanzapine or risperidone treatment on insulin sensitivity in schizophrenia or schizoaffective disorder Diabetes Obesity and Metabolism ·Todd A. Hardy, Robert R. Henry, Tammy Forrester, E U Cynk, Simon Pierre Eyene Ntsama, David M. Marks, Sunder Mudaliar	2011	14
11	Effects of saxagliptin on β ‐cell stimulation and insulin secretion in patients with type 2 diabetes Diabetes Obesity and Metabolism ·Robert R. Henry, Steven R. Smith, Sherwyn Schwartz, Sunder Mudaliar, Carolyn F. Deacon, Jens J. Holst, Carletta Carrington Wilson, 忠行藤本, James F. List	2011	40
12	Telmisartan Effects on Insulin Resistance in Obese or Overweight Adults Without Diabetes or Hypertension Journal of Clinical Hypertension ·Willa A. Hsueh, Giora Davidai, Robert R. Henry, Sunder Mudaliar	2010	13
13	A NEW THERAPY FOR NONALCOHOLIC FATTY LIVER DISEASE AND DIABETES? INT-747-THE FIRST FXR HEPATIC THERAPEUTIC STUDY Hepatology ·MEHMET AYKUT BOZKUR, Sunder Mudaliar, Ashley Friedman, Levitt Re, Linda Morrow, André Helbo, Paul Dillon, Paul Clopton, Mark Kipnes, Д. А. Шапиро	2009	18
14	Effects of intensive insulin therapy alone and with added pioglitazone on renal salt/water balance and fluid compartment shifts in type 2 diabetes Diabetes Obesity and Metabolism ·Sunder Mudaliar, Anna Chang, Vanita R. Aroda, Edward C. Chao, P. Burke, Sunita Baxi, Nabila A. Abd EL-Meseeh, Daniel T. O’Connor, Robert R. Henry	2009	14
15	Incretin Therapies: Effects Beyond Glycemic Control The American Journal of Medicine ·Sunder Mudaliar, Robert R. Henry	2009	31
16	Actos Now for the prevention of diabetes (ACT NOW) study BMC Endocrine Disorders ·Ralph A. DeFronzo, MaryAnn Banerji, George A. Bray, Thomas A. Buchanan, Stephen Clement, Robert R. Henry, Abbas E. Kitabchi, Sunder Mudaliar, Nicolas Musi, Robert E. Ratner, Peter D. Reaven, Dawn C. Schwenke, Frankie B. Stentz, Devjit Tripathy	2009	64
17	Impact of atypical antipsychotic therapy on leptin, ghrelin, and adiponectin Schizophrenia Research ·Hua Jin, Jonathan M. Meyer, Sunder Mudaliar, Dilip V. Jeste	2008	118
18	Assessment of Capacity to Consent to Research Among Older Persons With Schizophrenia, Alzheimer Disease, or Diabetes Mellitus Archives of General Psychiatry ·Barton W. Palmer, Laura B. Dunn, Paul S. Appelbaum, Sunder Mudaliar, Leon J. Thal, Robert R. Henry, Shahrokh Golshan, Dilip V. Jeste	2005	154
19	Insulin and insulin-like growth factor-1 action on human skeletal muscle: Preferential effects of insulin-like growth factor-1 in type 2 diabetic subjects Metabolism ·Theodore P. Ciaraldi, Leslie Carter, Selma Uzman, Pharis Mohideen, Sunder Mudaliar, Robert R. Henry	2002	24
20	Role of Glycemic Control and Protein Restriction in Clinical Management of Diabetic Kidney Disease Endocrine Practice ·Sunder Mudaliar, Robert R. Henry	1996	4

About Sunder Mudaliar

Sunder Mudaliar is a scholar working on Endocrinology, Diabetes and Metabolism, Physiology, Molecular Biology, Cell Biology and Endocrine and Autonomic Systems, having authored 118 papers that have together received 9.4k indexed citations. Recurring topics across this work include Metabolism, Diabetes, and Cancer (45 papers), Diabetes Treatment and Management (37 papers), Adipose Tissue and Metabolism (24 papers), Pancreatic function and diabetes (23 papers), Diabetes Management and Research (18 papers), Peroxisome Proliferator-Activated Receptors (16 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (13 papers) and Diet and metabolism studies (11 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (4.1k citations), Endocrine and Autonomic Systems (893 citations), Physiology (2.4k citations), Pharmacology (1.1k citations) and Epidemiology (2.1k citations). Sunder Mudaliar has collaborated with scholars based in United States, Italy and India. Frequent co-authors include Robert R. Henry, Theodore P. Ciaraldi, Svetlana E. Nikoulina, Dennis Dong Hwan Kim, Leslie Carter, J. Erickson, Raymond A Plodkowski, Eduardo Dunayevich, Frank L. Greenway and Maria Guttadauria. Their work appears in journals such as The Journal of Clinical Endocrinology & Metabolism, Diabetes, Diabetes Care, Diabetes Obesity and Metabolism and Metabolism.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact